By Emily Field ( July 25, 2016, 5:56 PM EDT) -- Merck and other drugmakers have urged the Ninth Circuit to uphold the toss of state-law claims that the companies failed to warn patients of pancreas problems from Type 2 diabetes drugs, saying the U.S. Food and Drug Administration would have rejected such warnings....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.